Each pen includes pen needles and instruction booklet.
The pen will last a new user 8 weeks (0.25mg x 4 weeks) and (0.5mg x 4 weeks)
One role of GLP-1 is to prompt the body to produce more insulin, which reduces blood sugar (glucose). For that reason, health care providers have used Semaglutide for more than 15 years to treat Type 2 diabetes.
But GLP-1 in higher amounts also interacts with the parts of the brain that suppress your appetite and signal you to feel full, it can cause significant weight loss — and a reduced risk of cancer, diabetes and heart disease — in people who are obese or overweight. 
Starting Dose: Initial recommended dosage is 0.25 mg once weekly for four weeks.
Storage: Store the pen at room temperature (59ºF to 86ºF / 15ºC to 30ºC) or refrigerated (36°F to 46°F / 2°C to 8°C) 
Side Effects: Common side effects include nausea, diarrhea, vomiting, Any concerns should be discussed with a healthcare provider.
-Semaglutide is FDA aproved in 2021 for age 12 and up
-powerfull appetite suppressant
-regulates blood sugar 
-fat burning agent
-promotes weight loss
-increase metabolism
-boost energy
-Save and effective